Aptose Biosciences Inc (APS) — Cash Flow-to-Debt Ratio
Aptose Biosciences Inc (APS) has a Cash Flow-to-Debt Ratio of -0.29x as of September 2025, meaning its operating cash flow of CA$-7.41 Million could theoretically repay 0% of its total liabilities (CA$25.79 Million) in one year. See APS FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Aptose Biosciences Inc Cash Flow-to-Debt Ratio (1996–2024)
Historical debt coverage capacity for Aptose Biosciences Inc across 29 annual periods. For the full cash flow conversion analysis, see APS cash flow metrics.
Annual Cash Flow-to-Debt Ratio for Aptose Biosciences Inc (1996–2024)
Year-by-year debt coverage analysis for Aptose Biosciences Inc. Check how high is Aptose Biosciences Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.45x | CA$-35.98 Million | CA$14.67 Million | ▲ +12.6% |
| 2023 | -2.81x | CA$-44.59 Million | CA$15.89 Million | ▼ -15.3% |
| 2022 | -2.43x | CA$-32.32 Million | CA$13.29 Million | ▲ +53.4% |
| 2021 | -5.22x | CA$-43.30 Million | CA$8.29 Million | ▼ -13.3% |
| 2020 | -4.61x | CA$-33.89 Million | CA$7.35 Million | ▼ -40.2% |
| 2019 | -3.29x | CA$-21.56 Million | CA$6.55 Million | ▲ +60.4% |
| 2018 | -8.32x | CA$-23.21 Million | CA$2.79 Million | ▼ -43.7% |
| 2017 | -5.79x | CA$-10.22 Million | CA$1.76 Million | ▲ +37.3% |
| 2016 | -9.24x | CA$-12.17 Million | CA$1.32 Million | ▼ -59.0% |
| 2015 | -5.81x | CA$-9.89 Million | CA$1.70 Million | ▼ -17.5% |
| 2014 | -4.95x | CA$-9.94 Million | CA$2.01 Million | ▼ -76.5% |
| 2013 | -2.80x | CA$-4.94 Million | CA$1.76 Million | ▼ -127.0% |
| 2012 | -1.23x | CA$-3.21 Million | CA$2.60 Million | ▲ +75.7% |
| 2011 | -5.09x | CA$-6.03 Million | CA$1.19 Million | ▼ -288.8% |
| 2010 | -1.31x | CA$-3.53 Million | CA$2.70 Million | ▼ -187.9% |
| 2009 | -0.45x | CA$-6.62 Million | CA$14.57 Million | ▲ +31.1% |
| 2008 | -0.66x | CA$-10.25 Million | CA$15.55 Million | ▼ -54.2% |
| 2007 | -0.43x | CA$-5.88 Million | CA$13.76 Million | ▲ +54.1% |
| 2006 | -0.93x | CA$-11.87 Million | CA$12.73 Million | ▲ +28.8% |
| 2005 | -1.31x | CA$-14.92 Million | CA$11.40 Million | ▲ +0.0% |
| 2004 | -1.31x | CA$-14.92 Million | CA$11.40 Million | ▲ +72.8% |
| 2003 | -4.82x | CA$-20.60 Million | CA$4.28 Million | ▼ -38.8% |
| 2002 | -3.47x | CA$-7.79 Million | CA$2.25 Million | ▲ +0.0% |
| 2001 | -3.47x | CA$-7.79 Million | CA$2.25 Million | ▼ -110.6% |
| 2000 | -1.65x | CA$-6.28 Million | CA$3.81 Million | ▼ -10.9% |
| 1999 | -1.49x | CA$-3.58 Million | CA$2.41 Million | ▲ +46.3% |
| 1998 | -2.77x | CA$-2.44 Million | CA$881.66K | ▲ +30.8% |
| 1997 | -4.00x | CA$-3.02 Million | CA$755.18K | ▼ -22.2% |
| 1996 | -3.27x | CA$-2.61 Million | CA$798.14K | — |